| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Amyloid-related iatrogenic atrophy of the brain: data transparency is an urgent safety priority
|
Ayton, Scott
|
|
|
24 |
3 |
p. 189-190
|
artikel
|
| 2 |
Amyloid-related iatrogenic atrophy of the brain: data transparency is an urgent safety priority – Authors' reply
|
Belder, Christopher R S
|
|
|
24 |
3 |
p. 190
|
artikel
|
| 3 |
Amyotrophic lateral sclerosis caused by hexanucleotide repeat expansions in C9orf72: from genetics to therapeutics
|
Mizielinska, Sarah
|
|
|
24 |
3 |
p. 261-274
|
artikel
|
| 4 |
An ethical framework to assess covert consciousness
|
Young, Michael J
|
|
|
24 |
3 |
p. 195-196
|
artikel
|
| 5 |
A pivotal recognition of the burden of encephalitis
|
The Lancet Neurology,
|
|
|
24 |
3 |
p. 179
|
artikel
|
| 6 |
Autoinflammatory encephalopathy due to PTPN1 haploinsufficiency: a case series
|
Zhu, Gaofeng
|
|
|
24 |
3 |
p. 218-229
|
artikel
|
| 7 |
Beyond the binary
|
Rosendale, Nicole
|
|
|
24 |
3 |
p. 194
|
artikel
|
| 8 |
Call for the creation of a European Parliament Intergroup on brain health
|
Bassetti, Claudio L A
|
|
|
24 |
3 |
p. 192
|
artikel
|
| 9 |
Clinical insights in enzyme replacement therapy for metabolic storage disorders: lessons from Pompe disease
|
van der Beek, Nadine A M E
|
|
|
24 |
3 |
p. 230-245
|
artikel
|
| 10 |
Correction to Lancet Neurol 2025; 24: 42–53
|
|
|
|
24 |
3 |
p. e7
|
artikel
|
| 11 |
Crossing the blood–brain barrier: emerging therapeutic strategies for neurological disease
|
Pedder, Josephine H
|
|
|
24 |
3 |
p. 246-260
|
artikel
|
| 12 |
Delivery of drugs through the blood–brain barrier: need for trials
|
Banks, William A
|
|
|
24 |
3 |
p. 185-187
|
artikel
|
| 13 |
Diana Cejas
|
|
|
|
24 |
3 |
p. 194
|
artikel
|
| 14 |
Direct oral anticoagulants for cerebral venous thrombosis
|
Garcia Guarniz, Ana-Lucia
|
|
|
24 |
3 |
p. 180-181
|
artikel
|
| 15 |
Direct oral anticoagulants versus vitamin K antagonists for cerebral venous thrombosis (DOAC-CVT): an international, prospective, observational cohort study
|
van de Munckhof, Anita
|
|
|
24 |
3 |
p. 199-207
|
artikel
|
| 16 |
Encephalitis: a growing global threat
|
Easton, Ava
|
|
|
24 |
3 |
p. 190-191
|
artikel
|
| 17 |
Expanding the spectrum of type 1 IFN neuroinflammation
|
Jafarpour, Saba
|
|
|
24 |
3 |
p. 183-185
|
artikel
|
| 18 |
For brain health, one drink a day is not better than none
|
Singh, Sanjula D
|
|
|
24 |
3 |
p. 191-192
|
artikel
|
| 19 |
Maria Trojano: advocate for real-world multiple sclerosis studies
|
Samarasekera, Udani
|
|
|
24 |
3 |
p. 193
|
artikel
|
| 20 |
Navigating the use of generative AI in peer review
|
Hart, Laura
|
|
|
24 |
3 |
p. 187
|
artikel
|
| 21 |
Neuroprotection in acute ischaemic stroke: reasons for optimism?
|
Price, Christopher
|
|
|
24 |
3 |
p. 181-183
|
artikel
|
| 22 |
Quad Gods: searching for self after neurological injury
|
Morgan, Jules
|
|
|
24 |
3 |
p. 198
|
artikel
|
| 23 |
Safety and efficacy of nerinetide in patients with acute ischaemic stroke enrolled in the early window: a post-hoc meta-analysis of individual patient data from three randomised trials
|
Tymianski, Michael
|
|
|
24 |
3 |
p. 208-217
|
artikel
|
| 24 |
Thank you to The Lancet Neurology's peer reviewers in 2024
|
The Lancet Neurology Editors,
|
|
|
24 |
3 |
p. e3-e6
|
artikel
|
| 25 |
The ATTeST trial in ataxia telangiectasia: some concerns
|
Willemsen, Michèl A A P
|
|
|
24 |
3 |
p. 188
|
artikel
|
| 26 |
The ATTeST trial in ataxia telangiectasia: some concerns – Authors' response
|
Horn, Biljana
|
|
|
24 |
3 |
p. 188-189
|
artikel
|
| 27 |
The unyielding voice: the story of Celine Dion
|
Araújo, Rui
|
|
|
24 |
3 |
p. 197
|
artikel
|
Tijdschrift beschrijving